Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2009 11:01

RNS Number : 2364W
Skyepharma PLC
24 July 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SKYEPHARMA PLC

GB00B3BFNB64

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 N/A

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

N/A 

An event changing the breakdown of voting rights

N/A 

Other (please specify):

N/A 

3. Full name of person(s) subject to the notification obligation:

 UBS INVESTMENT BANK

4. Full name of shareholder(s) (if different from 3.):

 UBS AG LONDON BRANCH

5. Date of the transaction and date on which the threshold is crossed or reached:

 22 JULY 2009

6. Date on which issuer notified:

 24 JULY 2009

7. Threshold(s) that is/are crossed or reached:

 6.07%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B3BFNB64

 1,147,010

 1,147,010

 1,452,702

 1,452,702

 -

 6.07%

 -

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 1,452,702

 6.07%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 ESTEBAN FRANK/ALEXA KOENIG

15. Contact telephone number:

 +41 44 239 5476

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKZLBLKDBZBBD
Date   Source Headline
12th Jul 20074:28 pmRNSDirector/PDMR Shareholding
11th Jul 20073:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20073:02 pmRNSRe: Share Purchase Plan
29th Jun 20071:27 pmRNSResult of AGM
29th Jun 20077:03 amRNSAGM Statement
27th Jun 200711:28 amRNSAppointment
26th Jun 20077:02 amRNSRe Agreement
21st Jun 200712:19 pmRNSHealthcare Conference
14th Jun 20079:30 amRNSHealth Care Conference
6th Jun 200711:28 amRNSHolding(s) in Company
31st May 20072:57 pmRNSShare Purchase Plan
31st May 200712:30 pmRNSRegulatory Approval
30th May 200710:51 amRNSHolding(s) in Company
15th May 20073:00 pmRNSAnnual Information Update
14th May 20071:30 pmRNSResearch Update
4th May 20074:47 pmRNSDirector Shareholding
4th May 20073:38 pmRNSEGM Result
4th May 20077:00 amRNSDelist from NASDAQ
3rd May 20071:18 pmRNSDirector/PDMR Shareholding
1st May 20075:10 pmRNSFurther re Final Results
1st May 20072:04 pmRNSRe: UBS Conference
26th Apr 20077:02 amRNSFinal Results
23rd Apr 20078:00 amRNSRegulatory Approval
18th Apr 200712:15 pmRNSCirc re. Incentive Plan
18th Apr 20077:01 amRNSEGM Circular
17th Apr 20074:57 pmRNSHolding(s) in Company
3rd Apr 20074:25 pmRNSDirector Shareholding
3rd Apr 20071:32 pmRNSInterest in Shares
3rd Apr 200710:16 amRNSAnnual Information Update
2nd Apr 20075:03 pmRNSInterest in Shares
2nd Apr 20073:39 pmRNSInterest in Shares
2nd Apr 20073:38 pmRNSRule 8.3- Skyepharma PLC-Amd
30th Mar 20075:20 pmRNSRule 8.3- Skyepharma PLC
26th Mar 200712:56 pmRNSTotal Voting Rights
26th Mar 20077:03 amRNSCompletion of Disposal
15th Mar 20077:01 amRNSAgreement for Zileuton CR
13th Mar 20073:55 pmRNSHolding(s) in Company
12th Mar 20074:53 pmRNSHolding(s) in Company
9th Mar 20079:21 amRNSPresentation at Conference
1st Mar 20074:41 pmRNSShare Purchase Plan
20th Feb 20077:03 amRNSNotification of Shares
14th Feb 20072:37 pmRNSPresentation at Conference
8th Feb 200710:48 amRNSEGM Statement
1st Feb 20073:21 pmRNSShare Purchase Plan
29th Jan 200712:48 pmRNSNotification of Interests
22nd Jan 20079:00 amRNSNotification of Shares
16th Jan 20077:01 amRNSCircular Posting
9th Jan 20078:49 amRNSUK Release Important Details
9th Jan 20077:01 amRNSInjectable Sale & Placing
9th Jan 20077:01 amRNSInjectable Sale & Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.